SEARCH

SEARCH BY CITATION

References

  • 1
    Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91100.
  • 2
    Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 16491657.
  • 3
    Park HS, Kim MW, Shin ES. Effect of weight control on hepatic abnormalities in obese patients with fatty liver. J Korean Med Sci 1995; 10: 414421.
  • 4
    Andersen T, Gluud C, Franzmann MB, Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 1991; 12: 224229.
  • 5
    Drenick EJ, Simmons F, Murphy JF. Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass. N Engl J Med 1970; 282: 829834.
  • 6
    Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997; 27: 103107.
  • 7
    DeWind LT, Payne JH. Intestinal bypass surgery for morbid obesity. Long-term results. JAMA 1976; 236: 22982301.
  • 8
    O'Leary JP. Hepatic complications of jejunoileal bypass. Semin Liver Dis 1983; 3: 203215.
  • 9
    Fox SR, Fox KS, Oh KH. The gastric bypass for failed bariatric surgical procedures. Obes Surg 1996; 6: 145150.
  • 10
    Antal SC. Prevention and reversal of liver damage following biliopancreatic diversion for obesity. Obes Surg 1994; 4: 285290.
  • 11
    Kral JG, Thung SN, Biron S, Hould FS, Lebel S, Marceau S, et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004; 135: 4858.
  • 12
    Chapman A, Kiroff G, Game P, Foster B, O'Brien P, Ham J, et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic review. Surgery 2004; 135: 326351.
  • 13
    Colman P, Thomas D, Zimmet P, Welborne T, Garcia-Webb P, Moore M. New classification and criteria for diagnosis of diabetes mellitus. Med J Australia 1999; 170: 375378.
  • 14
    Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356359.
  • 15
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412419.
  • 16
    Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program [letter]. Diabetes Care 1998; 21: 21912192.
  • 17
    Metropolitan Life Foundation. Height and Weight Tables: Metropolitan Life Foundation. New York: Metropolitan Life Insurance Company, 1983.
  • 18
    James J, Bosch KS, Zuyderhoudt FM, Houtkooper JM, van Gool J. Histophotometric estimation of volume density of collagen as an indication of fibrosis in rat liver. Histochemistry 1986; 85: 129133.
  • 19
    Vyberg M, Leth P. Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease. APMIS Suppl 1991; 23: 4652.
  • 20
    Freedman R, Uwaifo GI, Lutchman G, Promrat K, Kleiner D, Yanovski JA, et al. Changes in insulin sensitivity and improvements in liver histology in patients with non-alcoholic steatohepatitis (NASH) treated with Pioglitozone. Diabetes 2003; 52: A76.
  • 21
    Lee RG. Nonalcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler. HEPATOLOGY 1995; 21: 17421743.
  • 22
    Kleiner DE, Brunt EM, Van Natta ML, Behling C, Constos MJ, Cummings OW, et al. Design and validation of a histologic scoring system for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. HEPATOLOGY 2003; 38: 233A.
  • 23
    Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. HEPATOLOGY 2003; 37: 12021219.
  • 24
    Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 24672474.
    Direct Link:
  • 25
    O'Brien PE, Dixon JB, Brown W, Schachter LM, Chapman L, Burn AJ, et al. The laparoscopic adjustable gastric band (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg 2002; 12: 652660.
  • 26
    SPSS Inc. SPSS for Windows, version 10.0.5. Chicago: SPSS. Inc, 1999.
  • 27
    National Institutes of Health. Methods for voluntary weight loss and control. NIH Technology Assessment Conference Panel. Consensus Development Conference, 30 March to 1 April 1992. Ann Intern Med 1993; 119: 764770.
  • 28
    Luyckx FH, Desaive C, Thiry A, Dewe W, Scheen AJ, Gielen JE, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998; 22: 222226.
  • 29
    Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. HEPATOLOGY 2003; 38: 10081017.
  • 30
    Ong JP, Younossi ZM, Speer C, Olano A, Gramlich T, Boparai N. Chronic hepatitis C and superimposed nonalcoholic fatty liver disease. Liver 2001; 21: 266271.
  • 31
    Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 2000; 32: 209217.
  • 32
    Hickman IJ, Clouston AD, Macdonald GA, Purdie DM, Prins JB, Ash S, et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C [comment]. Gut 2002; 51: 8994.
  • 33
    Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Clouston A, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. HEPATOLOGY 1999; 29: 12151219.
  • 34
    Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. HEPATOLOGY 1997; 25: 108111.